A micro complement fixation assay was devised to measure the type-specificity of anti-M antibody. Unabsorbed sera were from rabbits hyperimmunized with heatkilled streptococci and from humans with naturally occurring antibody or immunized with purified M protein vaccines. These sera fixed complement only in the presence of homologous M proteins (serotypes 1, 3, 6, 12, and 14 Antisera. Hyperimmune anti-M sera were prepared in rabbits by foot-pad injection of heat-killed whole cells emulsified in complete Freund's adjuvant (6). These sera were not absorbed with heterologous serotypes of streptococci. All rabbit antisera exhibited strong precipitating bands in immunodiffusion analysis with homologous purified M protein. Human sera were obtained from volunteers (laboratory personnel), and plasma was from infants recently immunized with APM vaccines (11). The plasma samples were from peripheral blood collected in preservative-free heparin. All sera and plasma samples were heated at 56 C for 30 min and then stored at -70 C.
Type-specific immunity to group A streptococcal infection in man and experimental animals is directly related to levels of opsonic antibody (15) . Naturally occurring or induced anti-M antibody may be assayed directly for bactericidal (opsonic) activity by passive mouse protection or in vitro by Lancefield's phagocytic bactericidal test (13) . The long-chain test of Stollerman and Ekstedt (19) , in which type-specific antibody stimulates longchain growth of homologous streptococci, correlates well with high-titer bactericidal antibodies, but results with low-titer type-specific antisera often require statistical analysis for interpretation. Passive hemagglutination (HA) of tanned human erythrocytes coated with purified M proteins has been used to monitor antibody responses to M protein immunization (9, 11) . However, the latter procedure reveals extensive cross-reactions among serotypes, and titers frequently do not coincide with results obtained in the bactericidal assay.
Data are presented here demonstrating a close correlation between type-specific complementfixing and bactericidal antibodies. Results indicate that complement fixation may be of value as an index of protective antibody in group A streptococcal immunity.
MATERIALS AND METHODS
Antigens. Purified group A streptococcal M proteins were prepared as previously described (7) . Protein concentrations were determined by the method of Lowry et al. (17) . Preparation of alum-precipitated M protein (APM) vaccines for human use was as previously described (8) .
Antisera. Hyperimmune anti-M sera were prepared in rabbits by foot-pad injection of heat-killed whole cells emulsified in complete Freund's adjuvant (6) . These sera were not absorbed with heterologous serotypes of streptococci. All rabbit antisera exhibited strong precipitating bands in immunodiffusion analysis with homologous purified M protein. Human sera were obtained from volunteers (laboratory personnel), and plasma was from infants recently immunized with APM vaccines (11) . The plasma samples were from peripheral blood collected in preservative-free heparin. All sera and plasma samples were heated at 56 C for 30 min and then stored at -70 C.
Complement fixation assay. The method of Levine (16) was used with slight modification. The reaction mixture contained 0.5 ml of diluted M protein, 0.5 ml of diluted antiserum, 0.5 ml of complement, and 2.0 ml of diluent buffer. The diluent buffer contained 0.1% bovine serum albumin (Fraction V, Nutritional Biochemical Corp., Cleveland, Ohio), 0.01 M tris(hydroxymethyl)aminomethane (pH 7.4), 0.15 M sodium chloride, 5 X 104 M magnesium sulfate, and 1.5 X 104 M calcium chloride. Serum and antigen dilutions were made in this buffer. Guinea pig complement (lyophilized) and sheep hemolysin were purchased from Markham Laboratories, Chicago, Ill. The complement fixation by the M-anti-M system was carried out at 5 C for 16 (13); the procedure and scoring of the results have been described (9, 10) . Passive HA was carried out by the Microtiter system with human group 0 erythrocytes tanned and coated with purified M proteins (10) . RESULTS Anti-M sera were prepared in rabbits by hyperimmunization with heat-killed whole streptococci. The unabsorbed sera were reacted in the presence of complement with purified M proteins. Figure 1 shows the percentage of complement fixed with three dilutions of anti-12M serum and homologous M protein. Most hyperimmune sera diluted between 1: 50 and 1: 400 exhibited maximum complement fixation with M protein at concentrations ranging from 0.02 to 0.20 ,ug/0.5 ml of reaction mixture. For routine antiserum assays, sera were diluted 1:50 and 1:100, and antigen concentrations were selected at 0.02 and 0.05 ug/O.S ml. Table 3 . Each infant received three subcutaneous injections of vaccine at monthly intervals. The antibody levels at time zero and 30 days after the final injection are shown. It may be seen that those subjects who responded to the immunization with detectable amounts of bactericidal antibody also exhibited type-specific complement-fixing antibody. Although most of the subjects exhibited significant anti-M antibody responses to the vaccine as measured by passive HA, a high degree of crossreaction between types 3 and 6 was seen in this test.
In view of the disparity of results found when comparing passive HA and complement fixation assays of anti-M antibody, we attempted to determine whether immunoglobulin classes IgG or IgM contained the antibodies primarily responsible for the various serological reactions. Sera from two human donors and two rabbits with high anti-12 bactericidal antibody titers were fractionated on Sephadex G-200 (12) . The elution pattern for one of the human sera is shown in Fig.  2 . Effluent fractions 1 and 2, containing primarily 19S and 7S immunoglobulin, respectively, were each concentrated to the original serum volume. Immunodiffusion analysis (Fig. 3) with rabbit anti-human IgG and IgM showed the extent of separation of the IgG and IgM components. Fraction 2 appeared to be pure IgG, but fraction 1, the IgM component, contained a small amount of IgG. Anti-12 antibody assay of the IgG and IgM components of four sera fractionated on Sephadex G-200 is shown in Table 4 . In each case, two human sera and two rabbit hyperimmune sera exhibited type-specific complement-fixing activity only in the 7S fraction. Our previous studies showed that both the bactericidal and passive HA activity of rabbit anti-M immune sera also resided in IgG antibodies (8) .
DISCUSSION
It was demonstrated by Bone et al. (1) that complement-fixing antibodies to M proteins could be found in the sera of glomerulonephritic patients. The antigenic reagents were crude acid extracts of M proteins from isolated epidemic strains of group A streptococci. They demonstrated that complement-fixing antibodies generally were seen in those sera exhibiting type-specific bacteriostatic 4, 1971 COMPLEMENT FIXATION BY STREPTOCOCCAL ANTIBODY activity and capable of passive mouse protection. Although their antigens were unpurified and the complement-fixation test was a "macro" adaptation, their observations are consistent with the data in the present report.
The micro complement fixation test utilizing purified M proteins to assay type-specific antibody appears to reflect the bactericidal activity of anti-M antisera. In view of the acceptance of the in vitro bactericidal assay as the most convincing criterion for immunity to group A streptococcal disease (18), we propose that, if confirmed by further testing, titers of type-specific complementfixing antibodies may also be adopted for evaluating the parameters of the immune response to group A streptococci. The long-chain test of Stollerman and Ekstedt (19) likewise has been used in various laboratories as an assay of protective antistreptococcal antibodies (2) .
Micro complement fixation in the M protein system is optimal with fresh heat-inactivated serum. Sera stored for long periods of time or repeatedly frozen and thawed exhibit considerable anticomplementary activity. We extrapolate from the work of Ishizaka and Ishizaka (12) that agaggregated gamma globulin in old sera may be responsible for binding complement in the absence of M protein.
We have demonstrated by a variety of techniques such as immunodiffusion and cross-absorption that certain serotypes of M proteins share antigenic determinants. Cross-reactions seen in the passive HA assay probably result from these shared antigens rather than the presence of nonspecific contaminants in the purified M proteins (10) . The close correlation of the opsonic and complement-fixing capacity of immune anti-M sera may reflect the ability of these assays to utilize primarily high-affinity IgG antibody directed toward the major (type-specific) determinants of M proteins. Streptococcal bactericidal antibodies are generally obtained in rabbits only after hyperimmunization (6) and in humans after infection (14) or multiple doses of M protein vaccine (11) . These conditions are consistent with results obtained in other systems in which prolonged antigenic stimulation produces highaffinity antibody directed toward immunodominant determinants of antigens (3, 5) . We therefore assume that these latter antigenic determinants.
rather than the minor ones shared between M proteins, are mainly responsible for inducing measurable amounts of opsonic and complementfixing antibodies.
